It's that time of year when respiratory viruses start to circulate widely, but how can you tell the difference between the ...
The vaccine FluMist, manufactured by MedImmune, which was acquired by AstraZeneca in 2007, was first approved by the FDA in 2003 for individuals between five and 49 years of age. Its approval has ...
According to health experts, getting the flu vaccine can help reduce hospitalizations and death. A 2023 CDC study showed that ...
FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States ...
People ages 6 months and older should receive a vaccine every year. It is also recommended that people over 65 years old get ...
The FDA has approved FluMist nasal spray as the first at-home flu vaccine. People aged 18 and older can now self-administer ...
Health data show that COVID-19 still surpasses all other infectious respiratory illnesses as a cause of severe illness, ...
First Influenza Vaccine That Does Not Need to be Administered by a Health Care Provider ...
The latest strain of the COVID-19 virus, XEC, is circulating across the country. The new variant has been reported in at ...
The FDA is clearing the way for an at-home flu vaccines. A self-administered version of pharmaceutical giant AstraZeneca’s ...
No doctor? No problem. In a first, the US Food and Drug Administration on Friday approved a nasal spray flu vaccine for self-administration. Starting next fall, AstraZeneca's FluMist, which was ...
FluMist is the only nasal flu vaccine, but it is not new. The FDA approved it in 2003 for people 5 to 49 years old before ...